Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New hope for young leukemia patients?

17.11.2011
Researchers have identified a potential marker for leukemic relapse

The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse. The researchers' findings, published recently in Blood, demonstrate that the blame falls partially on a subset of white blood cells called "T cells." Until now, this process had been poorly understood.

"We have shown that a particular marker on the T-cells, PD-1, was found significantly more frequently in those young patients in whom relapses were about to occur," says lead author, Dr. Hugo Soudeyns, an investigator at the Sainte-Justine University Hospital Research Center, affiliated with Université de Montreal. "PD-1 is also an indicator of 'T cell exhaustion', a process whereby T cells lose their capacity to multiply and are less effective at fighting viruses and cancer cells."

Window of vulnerability

Dr. Soudeyns and his colleagues analyzed blood samples from young children who received an umbilical cord blood transplant for the treatment of blood disorders, including leukemia. They were particularly interested in studying the three to six month time period post-transplantation, when the children were most susceptible to both relapse and infection. During this time, expression of the PD-1 marker peaked, suggesting that many of these T cells were at the end of their life cycle and thus less effective.

"Our findings suggest that measurement of exhaustion markers such as PD-1 could serve as an early predictor of leukemic relapse – a very serious complication," says Dr. Soudeyns. "Our next step is to repeat these experiments in larger groups of patients."

The input of the ELISpot reader

Thanks to the financial support of the Fondation Centre de cancérologie Charles-Bruneau, Dr Soudeyns' team was able to count on a new ELISpot reader, which analyzes the reaction of cells to stimulus. This reader played an important part in the study of blood samples selected for this test. The Fondation is proud of its positive contribution to this research and congratulates Dr Soudeyns for this remarquable scientific breakthrough.

Leukemia and stem cell transplants

Leukemia is a type of blood cancer. Children with leukemia are frequently treated with chemotherapy and radiation to eradicate the cancer cells, but this treatment also leads to the destruction of both their red and white blood cells. To replenish these cells, leukemic children often undergo a bone marrow transplant. Another similar procedure involves transplantation of umbilical cord blood instead of bone marrow.

Study Details

The study, led by Dr. Hugo Soudeyns, an investigator in the Viral and Immune Disorders and Cancers research axis at the Sainte-Justine University Hospital Research Center and the Departments of Microbiology & Immunology and Pediatrics at Université de Montréal, was published online on August 2, 2011 in the scientific journal Blood. Dr. Natacha Merindol is first author, followed by Dr. Martin A. Champagne and Dr. Michel Duval. The study was published in the October 26, 2011 issue of Blood and was highlighted in an editorial that underscored the originality of the work.

The study was funded by le Fonds de recherche en santé du Québec (FRSQ), Héma-Québec, la Fondation Centre de cancérologie Charles-Bruneau, the Cole Foundation, and la Fondation de l'Hôpital Sainte-Justine.

William Raillant-Clark | EurekAlert!
Further information:
http://www.umontreal.ca

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>